Medicover AB
OTC:MCVEF
Medicover AB
OTC:MCVEF
Price:
27.25
USD
Market Closed
Market Cap:
$4.1B
Balance Sheet
Balance Sheet Decomposition
Medicover AB
Medicover AB
Balance Sheet Decomposition is not available for
Medicover AB
Medicover AB
Balance Sheet
Medicover AB
Medicover AB
Currency: EUR
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
17
|
18
|
45
|
38
|
35
|
47
|
82
|
0
|
51
|
70
|
|
| Cash Equivalents |
17
|
18
|
45
|
38
|
35
|
47
|
82
|
0
|
51
|
70
|
|
| Short-Term Investments |
0
|
0
|
2
|
28
|
2
|
40
|
196
|
9
|
14
|
13
|
|
| Total Receivables |
56
|
77
|
78
|
87
|
133
|
138
|
193
|
214
|
246
|
279
|
|
| Accounts Receivables |
0
|
0
|
69
|
78
|
117
|
126
|
160
|
175
|
196
|
246
|
|
| Other Receivables |
0
|
0
|
9
|
9
|
16
|
13
|
33
|
38
|
50
|
33
|
|
| Inventory |
24
|
26
|
31
|
30
|
37
|
53
|
72
|
58
|
59
|
69
|
|
| Other Current Assets |
0
|
0
|
4
|
6
|
9
|
11
|
9
|
14
|
11
|
16
|
|
| Total Current Assets |
97
|
122
|
161
|
189
|
216
|
289
|
552
|
335
|
381
|
447
|
|
| PP&E Net |
80
|
142
|
149
|
281
|
419
|
438
|
647
|
841
|
876
|
976
|
|
| PP&E Gross |
0
|
0
|
149
|
281
|
419
|
438
|
647
|
841
|
876
|
976
|
|
| Accumulated Depreciation |
0
|
0
|
117
|
198
|
249
|
266
|
330
|
403
|
525
|
646
|
|
| Intangible Assets |
19
|
32
|
36
|
51
|
75
|
65
|
75
|
126
|
122
|
133
|
|
| Goodwill |
107
|
119
|
127
|
150
|
293
|
289
|
372
|
496
|
517
|
524
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
|
| Long-Term Investments |
7
|
2
|
27
|
53
|
8
|
18
|
27
|
16
|
16
|
17
|
|
| Other Long-Term Assets |
3
|
4
|
4
|
4
|
9
|
12
|
12
|
16
|
28
|
40
|
|
| Other Assets |
107
|
119
|
127
|
150
|
293
|
289
|
372
|
496
|
517
|
524
|
|
| Total Assets |
313
N/A
|
420
+34%
|
504
+20%
|
728
+45%
|
1 020
+40%
|
1 111
+9%
|
1 684
+52%
|
1 832
+9%
|
1 941
+6%
|
2 138
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
46
|
59
|
23
|
25
|
45
|
54
|
61
|
61
|
273
|
339
|
|
| Accrued Liabilities |
0
|
0
|
34
|
42
|
51
|
75
|
89
|
88
|
100
|
120
|
|
| Short-Term Debt |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
15
|
2
|
34
|
146
|
50
|
81
|
92
|
224
|
241
|
|
| Other Current Liabilities |
9
|
11
|
34
|
29
|
40
|
50
|
94
|
113
|
110
|
116
|
|
| Total Current Liabilities |
59
|
85
|
95
|
130
|
282
|
228
|
325
|
354
|
501
|
566
|
|
| Long-Term Debt |
126
|
195
|
53
|
223
|
306
|
318
|
657
|
812
|
762
|
951
|
|
| Deferred Income Tax |
23
|
23
|
23
|
24
|
28
|
30
|
35
|
42
|
41
|
35
|
|
| Minority Interest |
4
|
6
|
4
|
4
|
42
|
36
|
45
|
36
|
32
|
25
|
|
| Other Liabilities |
12
|
17
|
29
|
35
|
45
|
51
|
105
|
113
|
110
|
97
|
|
| Total Liabilities |
224
N/A
|
327
+46%
|
204
-38%
|
415
+104%
|
702
+69%
|
663
-6%
|
1 167
+76%
|
1 357
+16%
|
1 445
+6%
|
1 673
+16%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
27
|
27
|
27
|
30
|
30
|
30
|
31
|
31
|
|
| Retained Earnings |
0
|
0
|
24
|
6
|
9
|
15
|
78
|
148
|
153
|
106
|
|
| Additional Paid In Capital |
0
|
0
|
320
|
320
|
320
|
459
|
459
|
459
|
459
|
418
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Equity |
89
|
93
|
22
|
28
|
20
|
55
|
49
|
162
|
145
|
90
|
|
| Total Equity |
89
N/A
|
93
+4%
|
300
+224%
|
313
+4%
|
317
+1%
|
448
+41%
|
518
+16%
|
475
-8%
|
497
+5%
|
465
-6%
|
|
| Total Liabilities & Equity |
313
N/A
|
420
+34%
|
504
+20%
|
728
+45%
|
1 020
+40%
|
1 111
+9%
|
1 684
+52%
|
1 832
+9%
|
1 941
+6%
|
2 138
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
97
|
97
|
133
|
133
|
133
|
148
|
148
|
149
|
150
|
150
|
|
Switch to:
Switch to:
See Also
Discover More
